- Home
- JAZZ vs CWAN Comparison
JAZZ vs CWAN Comparison
Compare JAZZ & CWAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAZZ
- CWAN
- Stock Information
- Founded
- JAZZ 2003
- CWAN 2004
- Country
- JAZZ Ireland
- CWAN United States
- Employees
- JAZZ N/A
- CWAN N/A
- Industry
- JAZZ Biotechnology: Pharmaceutical Preparations
- CWAN Computer Software: Prepackaged Software
- Sector
- JAZZ Health Care
- CWAN Technology
- Exchange
- JAZZ Nasdaq
- CWAN Nasdaq
- Market Cap
- JAZZ 7.3B
- CWAN 6.0B
- IPO Year
- JAZZ 2007
- CWAN 2021
- Fundamental
- Price
- JAZZ $108.07
- CWAN $23.09
- Analyst Decision
- JAZZ Strong Buy
- CWAN Buy
- Analyst Count
- JAZZ 13
- CWAN 9
- Target Price
- JAZZ $181.85
- CWAN $32.44
- AVG Volume (30 Days)
- JAZZ 1.3M
- CWAN 3.1M
- Earning Date
- JAZZ 05-06-2025
- CWAN 04-30-2025
- Dividend Yield
- JAZZ N/A
- CWAN N/A
- EPS Growth
- JAZZ 49.21
- CWAN N/A
- EPS
- JAZZ 7.51
- CWAN 1.71
- Revenue
- JAZZ $4,064,808,000.00
- CWAN $475,948,000.00
- Revenue This Year
- JAZZ $5.92
- CWAN $63.48
- Revenue Next Year
- JAZZ $4.22
- CWAN $29.35
- P/E Ratio
- JAZZ $14.39
- CWAN $13.48
- Revenue Growth
- JAZZ 5.76
- CWAN 23.21
- 52 Week Low
- JAZZ $95.49
- CWAN $17.63
- 52 Week High
- JAZZ $148.06
- CWAN $35.71
- Technical
- Relative Strength Index (RSI)
- JAZZ 47.97
- CWAN 49.23
- Support Level
- JAZZ $106.69
- CWAN $21.79
- Resistance Level
- JAZZ $110.48
- CWAN $22.66
- Average True Range (ATR)
- JAZZ 3.56
- CWAN 0.57
- MACD
- JAZZ 0.55
- CWAN -0.02
- Stochastic Oscillator
- JAZZ 68.77
- CWAN 45.86
About JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
About CWAN Clearwater Analytics Holdings Inc.
Clearwater Analytics Holdings Inc provides a SaaS solution for automated investment data aggregation, reconciliation, accounting and reporting services to insurers, investment managers, corporations, institutional investors and government entities. It earns revenue from providing access to its SaaS platform to customers, services that support the implementation on the SaaS platform, selling perpetual and term-based software licenses and providing maintenance and support and professional services under contracts with customers. The majority of the revenue is earned in the United States.